6.21 USD
-0.02 (-0.32%)
ChartMill assigns a Buy % Consensus number of 84% to EPRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.7. This target is 40.02% above the current price.
EPRX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EPRX.
In the previous month the buy percentage consensus was at a similar level.
EPRX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-24 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-06-26 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-14 | Rodman & Renshaw | Initiate | Buy |
EUPRAXIA PHARMACEUTICALS INC / EPRX FAQ
Can you provide the average price target for EUPRAXIA PHARMACEUTICALS INC stock?
10 analysts have analysed EPRX and the average price target is 8.7 USD. This implies a price increase of 40.02% is expected in the next year compared to the current price of 6.21.
How do analysts rate EUPRAXIA PHARMACEUTICALS INC (EPRX)?
The consensus rating for EUPRAXIA PHARMACEUTICALS INC (EPRX) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed EUPRAXIA PHARMACEUTICALS INC (EPRX)?
The number of analysts covering EUPRAXIA PHARMACEUTICALS INC (EPRX) is 10.